Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia

Documenti analoghi

• Characteristics of red blood cell transfusion among very preterm infants in China
  di: Lu Zheng, et al.
  Pubblicazione: (2024)
• Association of red blood cell transfusions with periventricular leukomalacia in very preterm infants
  di: Thomas Brune, et al.
  Pubblicazione: (2026)
• Re‐evaluating treatment thresholds in patient blood management: Female patients experience more perioperative anaemia and higher transfusion rates in major elective surgery
  di: Sumedha Arya, et al.
  Pubblicazione: (2024)
• Emergence of red blood cell alloantibodies and transfusion management in patients with warm autoantibodies at a tertiary care centre in British Columbia, Canada
  di: S. Hutspardol, et al.
  Pubblicazione: (2026)
• Cost‐effectiveness of a hypothetical assay to evaluate stored blood quality prior to transfusion
  di: Melissa C. Caughey, et al.
  Pubblicazione: (2025)